Hubei Goto BiopharmLtd Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Hubei Goto BiopharmLtd.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | 43.6% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Hubei Goto Biopharm Co.,Ltd. (SZSE:300966) Shares Fly 42% But Investors Aren't Buying For Growth
Oct 09Hubei Goto Biopharm Co.,Ltd. (SZSE:300966) Held Back By Insufficient Growth Even After Shares Climb 26%
May 12Hubei Goto BiopharmLtd's (SZSE:300966) Soft Earnings Are Actually Better Than They Appear
May 02Lacklustre Performance Is Driving Hubei Goto Biopharm Co.,Ltd.'s (SZSE:300966) Low P/S
Feb 28In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Hubei Goto BiopharmLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2024 | 547 | -14 | -261 | 152 | N/A |
6/30/2024 | 532 | 0 | -232 | 142 | N/A |
3/31/2024 | 569 | 23 | -233 | 101 | N/A |
12/31/2023 | 566 | 23 | -341 | 68 | N/A |
9/30/2023 | 543 | 23 | -418 | -15 | N/A |
6/30/2023 | 604 | 31 | -544 | -50 | N/A |
3/31/2023 | 604 | 31 | -535 | -45 | N/A |
1/1/2023 | 605 | 40 | -432 | -24 | N/A |
9/30/2022 | 592 | 64 | -301 | 57 | N/A |
6/30/2022 | 557 | 64 | -137 | 39 | N/A |
3/31/2022 | 570 | 76 | -132 | 8 | N/A |
1/1/2022 | 591 | 78 | -33 | 58 | N/A |
9/30/2021 | 595 | 76 | -70 | 1 | N/A |
6/30/2021 | 569 | 76 | -53 | 1 | N/A |
3/31/2021 | 573 | 71 | 28 | 45 | N/A |
12/31/2020 | 468 | 53 | -5 | 13 | N/A |
12/31/2019 | 465 | 73 | -25 | 9 | N/A |
12/31/2018 | 437 | 71 | -62 | -48 | N/A |
12/31/2017 | 334 | 47 | N/A | -22 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 300966's forecast earnings growth is above the savings rate (2.8%).
Earnings vs Market: Insufficient data to determine if 300966's earnings are forecast to grow faster than the CN market
High Growth Earnings: Insufficient data to determine if 300966's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 300966's revenue is forecast to grow faster than the CN market.
High Growth Revenue: Insufficient data to determine if 300966's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 300966's Return on Equity is forecast to be high in 3 years time